Device Trial Radar · NCT05701098
SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)
Last checked: Nov 19, 2026Latest source record: May 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
64
Actual
Start
Oct 9, 2023
Primary completion
Jun 18, 2025
Study completion Jul 31, 2025
Sponsor
- Lead sponsor
- SonoMotionNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 27, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to test the Break Wave™ system in patients with upper urinary tract stones. The main question it aims to answer is whether the device is safe and effective in fragmenting (breaking) stones. Participants will a) undergo the Break Wave™ procedure, b) have a telehealth visit at 2 weeks, and c) return for an imaging study at approximately 10 weeks post-procedure.
Conditions
- Kidney Stone
- Urolithiasis
- Nephrolithiasis
- Renal Calculi
- Kidney Calculi
- Nephrolith
- Urinary Calculi
Interventions
Break Wave extracorporeal lithotripsyDevice
The Break Wave device will be used to exert a low amplitude burst of ultrasound waves focused at the kidney stone. The primary components of the device include an ultrasound imaging system and a therapy probe driven by a high voltage generator. The probe will be placed on the patient's skin, the stone located via diagnostic ultrasound and up to 30 minutes of therapy will be delivered to the stone. The therapy probe accommodates coaxial alignment of an ultrasound imaging probe for treatment guidance.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Effectiveness EndpointTime frame: 10 +/- 2 weeks post final Break Wave procedure
- Primary Safety EndpointTime frame: During procedure and through 90 days post-procedure
Locations
10 sites in 2 countries. Site status is shown where the registry gives one.
University of California- San Diego
San Diego, California
University of California - San Francisco
San Francisco, California
Kaiser Permanente
Santa Clara, California
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.